Published in
Elsevier, Alzheimer's && Dementia :: Diagnosis, Assessment && Disease Monitoring, 1(2), p. 86-94, 2016
DOI: 10.1016/j.dadm.2015.12.004
Links
Tools
Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
Journal article published in 2016 by
Charlotte E. Teunissen 
,
John C. van Swieten,
Naura Elias,
Marleen J. A. Koel-Simmelink,
Sisi Durieux-Lu,
Arjan Malekzadeh,
Thang V. Pham,
Sander R. Piersma,
Tommaso Beccari ,
Lieke H. H. Meeter ,
Elise G. P. Dopper,
John C. Swieten,
Connie R. Jimenez,
Yolande A. L. Pijnenburg
,
John C. van Swieten,
Naura Elias,
Marleen J. A. Koel-Simmelink,
Sisi Durieux-Lu,
Arjan Malekzadeh,
Thang V. Pham,
Sander R. Piersma,
Tommaso Beccari ,
Lieke H. H. Meeter ,
Elise G. P. Dopper,
John C. Swieten,
Connie R. Jimenez,
Yolande A. L. Pijnenburg
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Reliable cerebrospinal fluid (CSF) biomarkers enabling identification of frontotemporal dementia (FTD) and its pathologic subtypes are lacking.